Our findings deepen the understanding of the molecular pathogenesis of thyroid diseases and, via DSigDB, predict candidate drugs targeting the phosphodiesterase family (e.g., PDE8B, PDE10A), offering preclinical rationale for developing “precision-targeted, bidirectional regulatory” therapeutic strategies. Here, PDE8B is linked to thyroid gland disorder.